Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Cadiz
Clinical trial register · Spain

Clinical Trials in Cadiz, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5875 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5875
Studies in scope
all four open statuses
3096
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Barcelona 3238 Madrid 3046 Valencia 1215 Seville 1054 Málaga 746
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Janssen Research & Development, LLC5 Novartis Pharmaceuticals5 Hoffmann-La Roche3 Fundación EPIC3 Pfizer3
Site location
Barcelona3238 Madrid3046 Valencia1215 Seville1054 Málaga746
All 453 locations
Target enrolment
to

Trials with a site in Cadiz

77 of 5875 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Not yet open
Predictive Score in Patients With Hematological Malignancies Colonized by Multidrug-resistant Enterobacteriaceae
NCT07396571Hemato-oncologic Patients, Colonization, Neutropenia, Enterobacteria Non Susceptible to Carbapenem Carrier
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Observational
535
Almería, Jerez de la Frontera, Vigo, Pamplona, Barcelona, Cadiz, Granada, Huelva
2026-09-04
Not yet open
Evaluation of Calcified Coronary Lesion Preparation With the Naviscore Scoring Balloon
NCT07650578Coronary Arterial Disease (CAD), Calcific Coronary Arteriosclerosis
University of Mons
Not applicable
200
Barcelona, Cadiz, Cáceres, Valencia, Valladolid
2026-07
Not yet open
Deprescription of Antidepressants in Primary Care (DAPriCare)
NCT06796946Deprescription, Antidepressants
University of Huelva
Early Phase 1
325
Cadiz
2026-06
Recruiting
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
NCT07227298Advanced/Metastatic Non-Small Cell Lung Cancer, Carcinoma, Non-Small Cell Lung, Non-Small Cell Lung Cancer
DrugsSigvotatug vedotin·PF-08634404
Pfizer
Phase 1/2
162
Jaén, Barcelona, Jerez de la Frontera, Madrid, Málaga, Valencia, Cadiz, Granada
2026-01-30
Recruiting
Kymera Therapeutics, Inc.
Phase 2
264
Cadiz, Jerez de la Frontera, Madrid, Mataró, Santander
2026-01-28
Recruiting
Tyra Biosciences, Inc
Phase 2
230
Valencia, Cadiz, Madrid
2025-12-22
Recruiting
Hospital Universitari Vall d'Hebron Research Institute
Not applicable
750
Barcelona, A Coruña, Alicante, Cabueñes, Cadiz, Elche, Getafe, Girona
2025-12-04
Active, closed
Pfizer
Phase 2
128
Manises, Cadiz, Granada, Madrid, Pontevedra
2025-11-13
Recruiting
Sanofi
Phase 2
208
Santiago de Compostela, Las Palmas de Gran Canaria, Manises, Cadiz, Granada, Madrid
2025-11-06
Recruiting
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
Phase 3
286
Cadiz, Córdoba, Jaén, Málaga, Valladolid
2025-11-05
Recruiting
Alnylam Pharmaceuticals
Phase 3
11,000
A Coruña, Alcalá de Henares, Alicante, Antequera, Badajoz, Barcelona, Burjassot, Cadiz
2025-09-22
Recruiting
Janssen Research & Development, LLC
Phase 3
220
A Coruña, Barcelona, Cadiz, Castellon, Ferrol, Jerez de la Frontera, Madrid, Málaga
2025-09-10
Recruiting
Ocus Innovation Ireland Limited
Phase 3
234
Barcelona, Cadiz, Madrid
2025-09-01
Recruiting
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
NCT06774131Upper Urinary Tract Urothelial Carcinoma, Urothelial Carcinoma
UroGen Pharma Ltd.
Phase 3
70
Barcelona, A Coruña, Madrid, Cadiz, Córdoba, Murcia, Seville, Valencia
2025-08-06
Recruiting
Ipsen
Phase 2
132
Barcelona, Cadiz, Madrid, Seville
2025-06-30
Active, closed
Immunovant Sciences GmbH
Phase 2
180
Bilbao, Cadiz, Córdoba, Mérida, Valencia
2025-06-30
By invitation
MoonLake Immunotherapeutics AG
Phase 3
835
Alicante, Badalona, Barcelona, Cadiz, Córdoba, Granada, Granollers, Madrid
2025-06-27
Active, closed
Novartis Pharmaceuticals
Observational
219
Cadiz, Granada, Huelva, Jaén, Marbella, Mallorca, Puerto Real, Santander
2025-06-16
Recruiting
Alexion Pharmaceuticals, Inc.
Phase 3
450
Badajoz, Barakaldo, Barcelona, Cadiz, Córdoba, Granada, Madrid, Málaga
2025-05-19
Recruiting
University of Seville
Observational
728
Cadiz, Córdoba, Huelva, Seville
2025-04-30
By invitation
Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0
NCT06823115Acute Kidney Injury, Fluid Overload, Prematurity Complications, Risk Factors
Indiana University
Observational
4,000
Cadiz
2025-03-01
Recruiting
Menarini Group
Phase 2
44
Barcelona, Cadiz, Girona, Madrid, Málaga, Santiago de Compostela
2025-02-18
Active, closed
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
2,000
Albacete, Alicante, Barakaldo, Burgos, Cadiz, Cantabria, Córdoba, Donostia / San Sebastian
2025-02-12
Recruiting
Airway Therapeutics, Inc.
Phase 2/3
366
Alicante, Barcelona, Bilbao, Cadiz, Lleida, Madrid, Málaga, Santiago de Compostela
2025-02-03
Active, closed
Novartis Pharmaceuticals
Phase 3
588
Cadiz, Badalona, Sabadell, Barcelona, Manises, Valencia, Madrid
2025-01-31
By invitation
Telematic Educational Intervention in Patients With Heart Failure.
NCT07317882Heart Failure, Heart Failure Patients
Maria Jose Santi Cano
Not applicable
100
Cadiz
2025-01-07
Recruiting
Hospital Universitario de Valme
Observational
9,000
Almería, Cadiz, Cartagena, Córdoba, Cuenca, Elche, Granada, Huelva
2025-01-01
Active, closed
Nutricia Research
Observational
250
Cadiz, Jerez de la Frontera
2024-12-20
Recruiting
Novartis Pharmaceuticals
Phase 3
60
Elche, Cadiz, Badalona, Esplugues, Pamplona, Barcelona, Málaga, Seville
2024-12-09
Active, closed
AstraZeneca
Phase 3
181
Barcelona, Cadiz, Madrid, Salamanca, Santiago de Compostela
2024-12-03
Recruiting
iPremom
Observational
7,473
Alicante, Barcelona, Vinaròs, Cadiz, A Coruña, Torrejón de Ardoz, El Palmar, San Cristóbal de La Laguna
2024-12-02
Active, closed
Nanordica Medical OU
Not applicable
136
Arcos de la Frontera, Cadiz, Jerez de la Frontera, León, Madrid, San Sebastián
2024-10-17
Active, closed
Ipsen
Phase 2
670
Barcelona, Cadiz, Madrid, Santander, Seville, Valladolid
2024-10-10
Recruiting
CRS Questionnaire Validation Project
NCT06970977Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps
The European Forum for Research and Education in Allergy and Airway Diseases
Observational
1,000
A Coruña, Barcelona, Cadiz, Madrid, Ponferrada, Santander, Seville, Valencia
2024-09-01
Active, closed
Celldex Therapeutics
Phase 3
976
Barcelona, Cadiz, Madrid, Pamplona, Pozuelo de Alarcón, Seville, Torrejón de Ardoz, Valencia
2024-07-19
Recruiting
Fundacion Oncosur
Phase 2
78
Badalona, Barcelona, Sabadell, Santander, Cadiz, Madrid, Málaga, Barakaldo
2024-07-05
Not yet open
Management of Early-onset Fetal Growth Restriction: Angiogenic Factors Versus Feto-placental Doppler
NCT05284474Fetal Growth Retardation, Preeclampsia, Placenta Diseases
Hospital Universitari Vall d'Hebron Research Institute
Not applicable
340
A Coruña, Alicante, Badalona, Barcelona, Cadiz, Elche, Getafe, Gijón
2024-06-03
Recruiting
Eli Lilly and Company
Phase 3
510
Andalucia, Barcelona, Cadiz, Galícia, Madrid, Pamplona
2024-04-29
Recruiting
Janssen Research & Development, LLC
Phase 3
641
A Coruña, Alzira, Barcelona, Cadiz, Castellon, Jerez de la Frontera, Madrid, Málaga
2024-04-18
Active, closed
Fundación EPIC
Observational
153
Alicante, Aravaca, Barcelona, Cadiz, Córdoba, El Palmar, Gijón, Huelva
2024-04-04
Active, closed
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
NCT06329401Pulmonary Fibrosis, Progressive Pulmonary Fibrosis, Pulmonary Fibrosis Secondary to Systemic Sclerosis, Pulmonary Fibrosis, Interstitial Lung Disease
DrugPirfenidone
Avalyn Pharma Inc.
Phase 2
375
Granada, Barcelona, Santander, Madrid, Málaga, Oviedo, Seville, Cadiz
2024-04-03
Recruiting
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
NCT06064877Metastatic Head-and-neck Squamous-cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
DrugsErbitux·Cetuximab
AVEO Pharmaceuticals, Inc.
Phase 3
410
Alicante, Badalona, Barcelona, Cadiz, Madrid, Málaga, Santander, Valencia
2024-01-11
Active, closed
Syndax Pharmaceuticals
Phase 2
145
L'Hospitalet de Llobregat, Sabadell, Santander, Majadahonda, Oviedo, Barcelona, Cadiz, Girona
2023-12-11
Recruiting
DESTINY Breast Respond HER2-(Ultra)Low Europe
NCT05945732Unresectable Breast Cancer, Metastatic Breast Cancer, HER2-low Expressing Breast Cancer, HER2-(Ultra)Low Expressing Breast Cancer
DrugTrastuzumab deruxtecan
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
2,295
Albacete, Alicante, Alzira, Barakaldo, Barcelona, Bilbao, Cadiz, Cáceres
2023-10-24
Recruiting
Hoffmann-La Roche
Phase 3
182
Cadiz, A Coruña, Barcelona, Murcia
2023-10-22
Recruiting
Ischemic And Bleeding Risk Assessment After TAVR
NCT06000943Aortic Valve Stenosis, Transcatheter Aortic Valve Replacement
Niguarda Hospital
Observational
2,500
Cadiz
2023-08-01
Recruiting
Study of ART6043 in Advanced/Metastatic Solid Tumors Patients (POLKA)
NCT05898399Advanced Solid Tumor, Metastatic Solid Tumor
DrugOlaparib
Artios Pharma Ltd
Phase 1/2
181
Granada, Valladolid, Barcelona, Cáceres, San Carlos, Cadiz, Madrid, Murcia
2023-06-30
Active, closed
University Hospital Virgen de las Nieves
Observational
287
Granada, Logroño, Murcia, Cadiz, Córdoba, Jaén, Madrid, Palma de Mallorca
2023-06-01
Active, closed
Bayer
Phase 3
985
Santiago de Compostela, Santander, Barcelona, Cadiz, Madrid, Málaga, Murcia, Seville
2023-04-03
Active, closed
Sequent Extended Study
NCT05788432Coronary Artery Disease, Ischemic Heart Disease
Fundación EPIC
Observational
2,040
Alava, Alicante, Badajoz, Badalona, Barakaldo, Barcelona, Cadiz, Castelló
2023-03-28
Active, closed
Janssen Research & Development, LLC
Phase 3
1,135
A Coruña, Algeciras, Barcelona, Cadiz, Castellon, L'Hospitalet de Llobregat, Lugo, Madrid
2023-03-23
Active, closed
Fundación EPIC
Not applicable
609
L'Hospitalet de Llobregat, A Coruña, Albacete, Alicante, Badalona, Barcelona, Cadiz, Castellon
2023-01-30
Recruiting
Alleviant ALLAY-HF Study
NCT05685303Heart Failure
Alleviant Medical, Inc.
Not applicable
700
Barcelona, Cadiz, Madrid, Salamanca, Valencia
2023-01-10
Recruiting
Endospan Ltd.
Observational
70
Cadiz, Vigo
2022-11-09
Active, closed
The Euro-CRAFT Registry
NCT05805462Coronary Microvascular Disease
CoreAalst BV
Observational
671
Cadiz, Madrid
2022-09-22
Active, closed
BeOne Medicines
Phase 3
799
Badalona, Burgos, Cadiz, Granada, L'Hospitalet de Llobregat, León, Madrid, Majadahonda
2022-03-10
Recruiting
National GMA Post-market Clinical Follow-up Study (GRACE)
NCT05636709Crohn Disease, Ulcerative Colitis
Adacyte Therapeutics SL
Observational
350
Albacete, Alicante, Badalona, Barcelona, Galdakao, Castellon, Cadiz, Córdoba
2022-01-11
Active, closed
Eli Lilly and Company
Phase 3
152
Santiago de Compostela, Cadiz, Córdoba, Badalona, Barcelona, L'Hospitalet Del Llobregat, Mataró, León
2021-12-20
Active, closed
Novartis Pharmaceuticals
Phase 3
1,000
Cadiz, Seville, Barcelona, Sant Joan Despí, Salt, Alcorcón, Getafe, Majadahonda
2021-12-16
Active, closed
Spanish Breast Cancer Research Group
Phase 3
27
A Coruña, Albacete, Alicante, Badajoz, Badalona, Barcelona, Bilbao, Cadiz
2021-09-14
Recruiting
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 3
434
Alicante, Badajoz, Badalona, Barcelona, Cadiz, Jaén, Madrid, Málaga
2021-07-06
Active, closed
Genmab
Phase 3
483
Badalona, Barcelona, Cadiz, Cáceres, Córdoba, Lleida, Madrid, Salamanca
2021-01-13
Active, closed
Instituto de investigación e innovación biomédica de Cádiz
Not applicable
105
Cadiz
2021-01-01
Active, closed
Janssen Research & Development, LLC
Phase 2
220
A Coruña, Badalona, Barcelona, Cadiz, Granada, Jerez de la Frontera, Madrid, Málaga
2020-12-18
Active, closed
Hoffmann-La Roche
Phase 3
864
A Coruña, Pozuelo de Alarcón, Vigo, Barcelona, Cadiz, Málaga
2020-11-26
Active, closed
Janssen Pharmaceutica N.V., Belgium
Phase 3
691
Cadiz, Ferrol, Jerez de la Frontera, Madrid, Málaga, Pamplona, Seville, Valencia
2020-11-12
Active, closed
Hoffmann-La Roche
Phase 3
985
A Coruña, Lleida, Pozuelo de Alarcón, Vigo, Barcelona, Cadiz, Madrid, Málaga
2020-10-26
Recruiting
Institut Cancerologie de l'Ouest
Observational
300
Cadiz, Cartagena, Granada, Ourense, Seville, Valencia
2020-07-10
Active, closed
Janssen Research & Development, LLC
Phase 3
2,517
A Coruña, Barcelona, Cadiz, Castellon, Jerez de la Frontera, Madrid, Manacor, Málaga
2019-06-11
Active, closed
UNICANCER
Phase 3
517
A Coruña, Cadiz, Madrid, Murcia, Santa Cruz de Tenerife
2019-01-17
Active, closed
Novartis Pharmaceuticals
Phase 3
1,882
Cadiz, L'Hospitalet de Llobregat, Barcelona, Donostia / San Sebastian, Salt, Majadahonda, Pozuelo de Alarcón, El Palmar
2018-12-28
Active, closed
Asthma Research in Children and Adolescents
NCT04480242Persistent Asthma, Asthma in Children, Asthma Exacerbation
Parc de Salut Mar
Observational
525
Cadiz, Seville, Zaragoza, Alava, Torrelavega, Barcelona, Madrid, Valencia
2017-07-26
Recruiting
UMC Utrecht
Phase 3
20,000
Barcelona, Cadiz, Córdoba, Madrid, Málaga, Ourense, Santander, Tortosa
2016-04-11
Active, closed
Geron Corporation
Phase 2/3
289
Cadiz, Majadahonda, Seville, Valencia, Barakaldo, Badalona, Barcelona, Madrid
2016-01-12
Active, closed
Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)
NCT02319837Hormone Sensitive Prostate Cancer, Prostate Cancer, Cancer of the Prostate
DrugsLupron·Eligard·Leuprorelin·Xtandi
Pfizer
Phase 3
1,068
Palma de Mallorca, Manresa, Santiago de Compostela, Barcelona, Cadiz, Girona, Madrid, Ourense
2014-12-17
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
982
Alcorcón, Barcelona, Cadiz, Córdoba, Madrid, San Sebastián de los Reyes, Valencia
2014-11-26
Recruiting
Patient Retrospective Outcomes (PRO)
NCT01550575Chronic Pain
Boston Scientific Corporation
Observational
15,000
Barcelona, Cadiz, Cartagena, Las Palmas, Logroño, Madrid, Majadahonda, Ourense
2012-04-03
Rows per page Showing 1–77 of 77
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-spain/city/cadiz

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,875 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 77 of those studies with a site in Cadiz.

How many clinical trials are recruiting in Cadiz?

34 of the 77 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 4 have not yet opened recruitment, 36 are active but closed to new participants, and 3 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Cadiz), 77 studies
PhaseStudiesRecruitingShare
Phase 3321341.6%
Observational201026%
Phase 212615.6%
Not applicable8210.4%
Phase 1/2222.6%
Phase 2/3212.6%
Early Phase 1101.3%

Most active sponsors

Lead sponsors with the most studies (Cadiz)
Lead sponsorStudiesRecruiting
Janssen Research & Development, LLC52
Novartis Pharmaceuticals51
Fundación EPIC30
Hoffmann-La Roche31
Pfizer31
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company21
Eli Lilly and Company21
Hospital Universitari Vall d'Hebron Research Institute21
Ipsen21
Adacyte Therapeutics SL11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.